CTOs on the Move

R1 RCM

www.r1rcm.com

 
R1 is a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers R1`s proven and scalable operating models seamlessly complement a healthcare organization`s infrastructure, quickly driving sustainable improvements to net patient revenue and cash flows while reducing operating costs and enhancing the patient experience.
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion
  • www.r1rcm.com
  • 434 West Ascension Way 6th Floor
    Murray, UT USA 84123
  • Phone: 312.324.7820

Executives

Name Title Contact Details
Sunny Dezendorf
Vice President of Analytics Profile
Neal Vaughan
Director End User Technology & IT Operations Profile
Wesley Eugene
Vice President of Information Technology Strategy and Process Innovation Profile
Bradley Karlin
US-Cyber Security Director Profile
Jay Sreedharan
Chief Technology and Digital Officer Profile

Jobs

SVP, Chief Information Security Officer

R1 RCM Remote
Details here:
https://r1rcm.wd1.myworkdayjobs.com/R1RCM/job/Remote-USA/US-Chief-Info-Security-Officer_R260000004894?source=LinkedIn

Similar Companies

Bioventus

Advancing orthobiologics to enhance the body’s ability to heal. Bioventus’ products are known for their safety, innovation, and effectiveness.

Professional Gem Sciences Inc

Professional Gem Sciences Inc is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Pharmaceutical Associates

Pharmaceutical Associates is a Greenville, SC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cellular Dynamics International, Inc

Cellular Dynamics International, Inc. develops and manufactures human cells in the United States of America, Europe, Japan, and internationally. The company’s proprietary iCell Operating System comprises human cells in multiple cell types (iCell products), human induced pluripotent stem cells (iPSCs), and custom iPSCs and iCell products (MyCell products). It offers iCell Cardiomyocytes, which are purified human heart cells that beat in a dish and behave just like the heart cells found in the human body for in vitro drug discovery, toxicity testing, and chemical safety, as well as in vivo cellular therapeutics research and development, and stem cell banking; and iCell Neurons that are purified human neurons typical of the forebrain for pre-clinical drug discovery, neurotoxicity testing, and disease modeling for Alzheimer’s diseases, Parkinson’s diseases, Huntington’s diseases, and others. The company also provides iCell Endothelial cells, which are interior surface blood vessel cells for use in vascular biology research, such as angiogenesis, atherosclerosis, inflammation, and other life science research; and iCell Hepatocytes that are human liver cells for pre-clinical drug discovery, hepatotoxicity testing, disease modeling, and other life science research. In addition, it offers MyCell products for making iPSCs for stem cell banking, cell modeling of specific ethnic or disease populations, and genetic engineering for in vitro research; and media and reprogramming kits for making iPSCs for limited research use. The company serves biopharmaceutical companies, government research institutions, academic and nonprofit research institutions, contract research organizations, and stem cell banks. Cellular Dynamics International, Inc. was founded in 2004 and is headquartered in Madison, Wisconsin.

Alkermes

Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) diseases. The company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio.